Connect with us

Global Trends and Politics

FDA Cuts Education and Training Division

Published

on

FDA Cuts Education and Training Division

Introduction to the FDA Restructuring

The Food and Drug Administration has gutted a division responsible for training agency staff and outside health-care professionals on an array of key public health, regulation and safety practices and supporting professional development for employees. In an email viewed, workers were notified that the Division of Learning and Organizational Development, or DLOD, faces cuts under Robert F. Kennedy Jr.’s broader plan to restructure the Department of Health and Human Services, or HHS. All of the more than 30 employees in the division were laid off.

Impact of the Cuts

While it was a small team within the FDA, it was a key resource for the entire agency and external doctors, nurses, pharmacists and pharmacy technicians, among other professionals. Kennedy is slashing 10,000 jobs at HHS, including roughly 3,500 full-time employees at the FDA, to focus on what HHS called "streamlining operations and centralizing administrative functions." The FDA is responsible for regulating and overseeing the safety, efficacy, and security of human and veterinary drugs, medical devices, food and cosmetics, among other items.

Effect on Public Health

HHS has said the cuts at the agency will not affect inspectors or reviewers of drugs, medical devices or food, and will primarily target workers deemed as having unnecessary responsibilities. But reports suggest that the Trump administration is eliminating some employees who played a key role in protecting public health, such as top veterinarians overseeing the FDA’s bird flu response amid outbreaks in poultry and U.S. dairy cows, along with several recent human cases.

Reinstatement of Personnel and Programs

Kennedy last week said some personnel and programs at federal agencies affected by his sweeping reductions will be reinstated, but it is unclear if that includes DLOD employees. The FDA did not immediately respond to a request for comment.

Cancellation of Activities and Programs

The division is canceling all planned activities, including scientific and regulatory education along with leadership and organizational development, according to the email. It is also scrapping the processing and approval of any so-called continuing education activities across the FDA, which refers to formal educational programs that help agency staff and external health-care professionals stay up to date on medical science, public health and regulatory practices, the email said.

Training and Education Programs

For example, some programs trained agency staff and external doctors, nurses and pharmacists about opioid safety, avoiding medication errors, infectious and rare diseases, clinical trials and using artificial intelligence to support regulatory decisions, according to two FDA employees, who requested anonymity to speak freely. The division also held monthly presentations to highlight research across the agency – such as a recent study on tobacco use – and its impact on protecting public health, the employees said.

Impact on Healthcare Professionals

There are now no staff available to award credits, or points for completing approved educational activities, such as lectures, online modules or workshops, according to one FDA employee. Depending on the state, health-care professionals must earn a certain number of credits each year or licensing cycle to maintain their credentials and stay up to date with medical knowledge and standards.

Loss of Central Resource

The FDA is also losing a central resource that employees can go to for professional development and training. "With the removal of DLOD, there’s a great deal of uncertainty about how learners and professionals will adapt," one of the FDA employees said. "They are now responsible for independently finding and selecting their own courses, which may result in confusion or inefficiency."

Funding and Accreditation

One office in the division was fully funded by so-called user fees, not taxpayer dollars, according to the two FDA employees. The FDA collects those fees from companies that produce certain products like drugs and medical devices and from other entities, such as certain certification bodies. The Trump administration has cited federal cost savings as part of its justification for laying off employees at HHS, raising questions about why it targeted that unit.

Conclusion

The elimination of the Division of Learning and Organizational Development has significant implications for the FDA and the healthcare professionals it serves. The loss of this division will likely lead to confusion and inefficiency in the training and education of agency staff and external healthcare professionals, ultimately affecting public health.

FAQs

Q: What is the Division of Learning and Organizational Development (DLOD)?
A: The DLOD is a division within the FDA responsible for training agency staff and outside health-care professionals on key public health, regulation, and safety practices.
Q: Why was the DLOD eliminated?
A: The DLOD was eliminated as part of Robert F. Kennedy Jr.’s plan to restructure the Department of Health and Human Services (HHS) and reduce costs.
Q: How many employees were laid off from the DLOD?
A: All 30+ employees in the DLOD were laid off.
Q: What kind of training and education programs did the DLOD offer?
A: The DLOD offered training and education programs on topics such as opioid safety, avoiding medication errors, infectious and rare diseases, clinical trials, and using artificial intelligence to support regulatory decisions.
Q: How will the elimination of the DLOD affect healthcare professionals?
A: The elimination of the DLOD will make it more difficult for healthcare professionals to earn the credits they need to maintain their credentials and stay up to date with medical knowledge and standards.

Continue Reading

Global Trends and Politics

Baby items get pricier, congressional report says

Published

on

Baby items get pricier, congressional report says

Introduction to Tariff Policies and Baby Gear

The cost of some baby gear has risen in recent weeks due to President Donald Trump’s tariff policies, according to a new congressional report. The report analyzed the prices of five common items bought for babies and found that they have increased by 24%, or by $98 combined, between April 1 and June 9.

Impact of Tariff Policies on Baby Gear

The analysis tracked the prices of five popular baby gear categories: car seats, bassinets, strollers, high chairs, and baby monitors. It used data from baby registry website Babylist to determine the price increases. The findings show that new parents are facing higher prices for essential items, which can be a significant burden on their budgets.

Companies’ Responses to Tariff Policies

Some companies have said they will work to mitigate the impact of the levies and offset the costs to consumers, while others, including Best Buy and Costco, have said they already raised some prices. Walmart and Target said they plan to hike prices on some items. Baby gear sold in the U.S. is specifically at risk of tariff impact because 97% of strollers and 87% of car seats are manufactured in China, according to Babylist.

Price Increases for Specific Baby Gear

The committee’s report tracked the prices of the most popular Amazon listings for products from five of Babylist’s categories of baby goods. The Amazon bestsellers included items from brands Graco, AirClub, Summer by Ingenuity, Evenflo, and HelloBaby. The report measured the price increases over time using the price-checking websites Keepa.com and Camelcamelcamel.com. Of the five items studied, the Graco car seat saw the highest price increase, with a 44.8% increase over the measured time period.

Response from Graco Owner Newell Brands

A spokesperson for Graco owner Newell Brands told CNBC in a statement that the report appears to have started collecting data on the Graco car seat during a period when retailers were running a promotion. The spokesperson said the car seat was on sale on April 1, so the price was hiked by about $20, not by $43, as suggested in the report. Executives from Newell said during an April 30 earnings call that the company had raised prices on its baby gear by about 20%.

Broader Impact of Tariff Policies on Baby Gear

A broader Babylist analysis of 11 categories, including products like bouncers and diaper bags, found that costs increased by an average of $400 combined between March 10 and June 3. Those higher prices for new parent households in the U.S. amount to $875.2 million in total additional costs, according to the analysis and based on data from the American Community Survey. The study found particular risk for parents in California, with parents in that state collectively facing a potential $100.3 million in additional baby costs this year.

Conclusion

The tariff policies implemented by President Donald Trump have resulted in significant price increases for baby gear, making it more difficult for new parents to afford essential items. The report’s findings highlight the need for policymakers to consider the impact of tariff policies on consumers, particularly those with limited budgets. As the trade tensions between the U.S. and China continue to escalate, it is likely that the prices of baby gear will continue to rise, affecting many families across the country.

FAQs

Q: What is the main reason for the price increase in baby gear?
A: The main reason for the price increase in baby gear is the tariff policies implemented by President Donald Trump.
Q: Which baby gear categories have been most affected by the tariff policies?
A: The baby gear categories most affected by the tariff policies are car seats, bassinets, strollers, high chairs, and baby monitors.
Q: How much have the prices of baby gear increased since April 1?
A: The prices of baby gear have increased by 24%, or by $98 combined, since April 1.
Q: Which state is most affected by the price increase in baby gear?
A: California is the state most affected by the price increase in baby gear, with parents facing a potential $100.3 million in additional baby costs this year.
Q: What is the total additional cost of baby gear for new parent households in the U.S.?
A: The total additional cost of baby gear for new parent households in the U.S. is $875.2 million.

Continue Reading

Global Trends and Politics

Amex Platinum, Chase Sapphire Get 2025 Refresh

Published

on

Amex Platinum, Chase Sapphire Get 2025 Refresh

Introduction to the Premium Credit Card Rivalry

The long-running rivalry between the country’s top premium credit cards is about to heat up again. JPMorgan Chase announced last week that a refresh of its Sapphire Reserve — the travel and dining rewards card that went viral when it arrived in 2016 — was imminent.

Response from American Express

In response, American Express on Monday said that "major" changes were coming to its consumer and business Platinum cards later this year. While short on details, the New York-based card company said that its update would be its largest ever investment in a card refresh. "We are going to double down on the things we know based on the data that our card members love," said Amex President of U.S. Consumer Services Howard Grosfield in an interview. "But more importantly, we’ll bring a whole bunch of new and exciting benefits and value that will far, far, far exceed the annual fee."

History of Premium Credit Cards

American Express pioneered the premium credit card space decades ago with cards that bundled perks at airlines and hotels with access to its own network of high-end airport lounges. But JPMorgan shook up the industry in 2016, igniting stiff competition among card issuers with a lavish sign-on bonus and other incentives for its Sapphire card.

Expected Changes and Updates

The expectation among industry experts is that both companies will offer ever-longer lists of perks in travel, dining and experiences, while potentially raising their annual fees, as has been the pattern with recent updates. The Platinum card has a $695 annual fee, while the Sapphire has a $550 fee. On Reddit and other forums, card users circulated rumors that JPMorgan was hiking the annual fee on its Sapphire product to $795. A JPMorgan spokesperson declined to comment.

Launch of the New Platinum Card

The new Platinum card will launch in the fall, Grosfield said. The updates from both companies are expected to further intensify the competition in the premium credit card market.

Conclusion

The rivalry between JPMorgan Chase and American Express is set to heat up with the upcoming refresh of their premium credit cards. With expected updates and new benefits, card users can look forward to enhanced perks and services. However, the potential increase in annual fees may be a concern for some users.

FAQs

Q: What changes can we expect from the refresh of the Sapphire Reserve and Platinum cards?

A: The changes are expected to include new benefits and perks in travel, dining, and experiences, as well as potential increases in annual fees.

Q: When will the new Platinum card launch?

A: The new Platinum card will launch in the fall.

Q: How much is the annual fee for the Platinum card?

A: The annual fee for the Platinum card is $695.

Q: How much is the annual fee for the Sapphire card?

A: The annual fee for the Sapphire card is $550.

Q: Are there rumors of a price increase for the Sapphire card?

A: Yes, there are rumors that JPMorgan may hike the annual fee on its Sapphire product to $795, but a JPMorgan spokesperson declined to comment.

Continue Reading

Global Trends and Politics

Battle Over Jimmy Buffett Estate

Published

on

Battle Over Jimmy Buffett Estate

A court battle over the late singer Jimmy Buffett’s $275 million estate has highlighted the growing litigation over the trillions of dollars in wealth being passed down to spouses and families, experts said. Jimmy Buffett’s widow, Jane Buffett, filed a petition last week in a Los Angeles court to remove her co-trustee, Richard Mozenter, from the marital trust created to support her after the singer’s death in 2023.

Background of the Dispute

Jane Buffett, who married Jimmy in 1977, alleged that Mozenter has been “openly hostile and adversarial” toward her and has refused to give her details on the trust and its financials. She alleged Mozenter is collecting “excessive fees” of $1.7 million a year and that he’s mismanaging the trust assets, projecting income of only $2 million, implying annual returns of less than 1%. Mozenter has filed his own lawsuit in Palm Beach County, Florida, alleging that Jane has been “completely uncooperative” in his efforts to manage the trust.

Jimmy Buffett’s Estate Plan

Jimmy Buffett planned carefully for the afterlife. His will, first written more than 30 years ago and amended in 2017 and again in 2023, directed that most of his assets be placed in a marital trust for Jane. The trust was created “for the wife’s sole benefit of her lifetime,” according to legal filings. The three children they shared — Savannah, Delaney, and Cameron — are the so-called remainder beneficiaries of the marital trust, which means they will receive any remaining assets left after Jane’s death.

Assets in the Estate

The assets Buffett left were substantial. A successful businessman and entrepreneur, Buffett built a brand empire and merchandising business that far surpassed his song rights and touring. According to the filings, the assets in the estate included $34.5 million of real property; $15 million of equity in a company called Strange Bird Inc., which held Buffett’s interest in various planes; $2 million in musical equipment; $5 million in vehicles; and $12 million in other investments. One of the largest assets is Buffett’s stake in Margaritaville, the chain of restaurants, bars, hotels, and merchandising that commercialized the Buffett lifestyle.

The Role of Co-Trustees in Estate Planning

Trust lawyers said the case is part of a growing wave of lawsuits related to inheritances and trusts. Over $100 trillion of wealth is expected to be passed down from older generations to spouses and families over the next 25 years, according to Cerulli Associates. More wealth being passed down means more litigation, since families often fight over who gets what. The Buffett case has reflected a different, but equally common, source of disputes: dueling trustees.

Potential Outcomes of the Case

Since the lawsuits were filed in different states, courts will first have to decide where the case will be heard. After that, a judge will start arguments and ultimately decide a path forward. Attorneys said judges have typically sided with the outside trustee (in this case Mozenter). Yet increasingly, they have been siding with spouses — which could mean Mozenter is removed. More likely, attorneys said, a judge will determine that the relationship between Mozenter and Jane is unworkable and name a new, professional or corporate trustee from a trust company or bank to replace them both.

Lessons for Families Planning Wealth Transfers

The Buffett case offers two important lessons for families planning wealth transfers. First, they said wealth holders should communicate the plans for their estates before they die so no one is surprised. If Buffett had explained the co-trustee roles to both Jane and Mozenter, perhaps tensions would have been minimized. The second lesson is that friends or business associates don’t always make good trustees. While today’s wealthy often name a trusted friend to a family trust, the trustee may have a different relationship with the beneficiary and can see themselves as carrying out the wishes of the descendant — which is not the job of a trustee.

Conclusion

The Jimmy Buffett estate battle highlights the importance of careful estate planning and communication. As the case moves forward, it will be important to watch how the court navigates the complex issues involved. The outcome of the case will have significant implications for the management of the Buffett estate and the distribution of its assets.

FAQs

Q: What is the estimated value of Jimmy Buffett’s estate?
A: The estimated value of Jimmy Buffett’s estate is $275 million.

Q: Who are the beneficiaries of the marital trust created by Jimmy Buffett?
A: The beneficiaries of the marital trust are Jane Buffett, Jimmy’s widow, and their three children, Savannah, Delaney, and Cameron, who are the remainder beneficiaries.

Q: What is the role of a co-trustee in estate planning?
A: A co-trustee is appointed to manage the trust alongside the beneficiary, in this case, Jane Buffett. The co-trustee is responsible for making decisions about the management of the trust assets.

Q: What are the potential outcomes of the case?
A: The potential outcomes of the case include the removal of Richard Mozenter as co-trustee, the appointment of a new professional or corporate trustee, or a continuation of the current arrangement with modifications.

Q: What lessons can be learned from the Jimmy Buffett estate battle?
A: The Jimmy Buffett estate battle highlights the importance of careful estate planning, communication, and the selection of appropriate trustees. It also emphasizes the need for clear roles and responsibilities for co-trustees and the importance of considering the impact of estate planning decisions on family relationships.

Continue Reading
Advertisement

Our Newsletter

Subscribe Us To Receive Our Latest News Directly In Your Inbox!

We don’t spam! Read our privacy policy for more info.

Trending